fbpx Diary from FENS 2014 - Day Five | Scienza in rete

Diary from FENS 2014 - Day Five

Primary tabs

Read time: 3 mins

Every attendant of the FENS today spent some of his time to greet and share the contact with the most relevant colleagues found during this conference. One of the most important and interesting aspects of these events is indeed the possibility of creating networks of contacts, collaborations and nonetheless friendship within this big and active community. The next appointment of this huge event will be in two years in Copenhagen thus… “Arrivederci” in Copenhagen!

3 – Lisa Holt, University of Cambridge, United Kingdom

Lisa Holt focused all of her carrier so far in understanding the processes occurring during axon elongation. Her efforts revealed the mechanisms behind attraction cues during axon growth, showing how protein synthesis in the growth cone of the axon is necessary to polarize the axon toward the attractive cue. Most recent studies made in her lab were aimed to identify the specific genes transduced in the growth cone by very specific and unbiased assays. These studies can lead to new breaches in the understanding the rules of the axon growth processes, a series of very precise mechanisms at the base of the high complexity of the brain.

2 – Patrick Kahold, University of Maryland, USA

Patrick Kahold’s subjects of studies are the circuits formed in development by the subplate. These cells are a temporary population of cells formed during the development of the cerebral cortex, which is necessary for an appropriate wiring between the thalamus and the cortex. The approaches used in his lab allowed creating a map of connectivity between different type of cells of the subplate and the cortex and how these circuits evolve during time. His lab managed to demonstrate the existence of a feedback circuit between cortex and subplate. Such a circuit is very important for the strengthening of thalamic projections to the cortex, which are key processes for a correct wiring of the brain. His technique can also be adapted to study many different type of circuits in a more widespread fashion.

1 – Svante Pӓӓbo, Max Plank Institute, Franckfurt, Germany

Svante Pӓӓbo is a leading expert in human evolution studies. His efforts lead to the sequencing and the comparison of the Neanderthal, human and Denisovan genome. His works led to a deep insights on the geographical, historical and evolutionary origin of the human species, showing how the first humans emerged from Africa and spread in all the continents after mixing with few other hominids. His studies are also focusing on understanding which main genomic changes made it possible to develop those cognitive functions that are unique in humans amongst hominid species, an exciting and very promising field of study that can allow us to focus more functional studies on the human specific genes or mutation that will be identified.

Articoli correlati

Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


prossimo articolo

Immunoterapia contro i tumori: le applicazioni di una scoperta da Nobel

Una ricercatrice osserva in controluce alcune piastre di Petri in un laboratorio scientifico

Il Nobel per la Medicina 2025 è stato assegnato a tre immunologi per le loro scoperte sulla tolleranza immunologica periferica, che hanno rivoluzionato le conoscenze sul sistema immunitario. Hanno aperto la strada a nuovi importanti campi di ricerca, identificando per la prima volta i linfociti T regolatori, che funzionano da freni del sistema. Sergio Abrignani, docente di Immunologia all’Università degli Studi di Milano, ci ha raccontato di come proprio attraverso innovative ricerche sui T regolatori sta sviluppando nuovi farmaci, basati su anticorpi monoclonali, per l’immunoterapia dei tumori. Crediti immagine: CDC/Unsplash

In campo oncologico, l’immunoterapia ha rappresentato un cambio di paradigma: invece di attaccare le cellule tumorali, come si fa con la chemioterapia o la radioterapia, si stimolano le cellule del sistema immunitario del paziente ad attaccarle.

Attuata da circa quindici anni, l’immunoterapia ha portato a un significativo balzo in avanti nella cura di diversi tumori, fra i quali il melanoma, i tumori del polmone non a piccole cellule, i tumori del rene – migliorandone nettamente la prognosi.